| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -6,419,566 | -2,065,825 |
| Amortization of debt discount | 576,277 | 57,864 |
| Depreciation and amortization expense | 182,724 | 106,646 |
| Change in fair value of derivative liability | -2,340 | -1,477 |
| Loss on extinguishment of debt | -416,155 | - |
| Preferred shares issued with debt | 401 | 401 |
| Accounts receivable | 91,401 | 14,071 |
| Prepaid expenses | 5,179 | 105,179 |
| Inventory | 145,771 | 95,573 |
| Other asset | 20,000 | 0 |
| Accounts payable and accrued liabilities | 4,759,305 | 1,573,277 |
| Cash provided (used) by operating activities | -744,715 | -540,984 |
| Purchase of property and equipment | 335,411 | 110,582 |
| Cash used by investing activities | -335,411 | -110,582 |
| Proceeds from issuance of debt | 1,100,000 | 1,100,000 |
| Cash provided by financing activities | 1,100,000 | 1,100,000 |
| Net increase in cash | 19,875 | 448,434 |
| Cash and cash equivalents at beginning of period | 1,165,820 | - |
| Cash and cash equivalents at end of period | 1,185,695 | - |
Regenerative Medical Technology Group Inc. (RMTG)
Regenerative Medical Technology Group Inc. (RMTG)